Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA)
NCT01217086
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
617
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
DRUG:
Infliximab
Sponsor
Celltrion